CMS Final Rule on Covered Outpatient Drugs
The Centers for Medicare & Medicaid Services (CMS) issued the Covered Outpatient Drugs final rule with comment on…
Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Office of Management and Budget To Revise Fraud Rules by Spring
The White House Office of Management and Budget released their 2016 rule agenda at the close of last year, laying out…
Improving Regulatory Transparency for New Medical Therapies Act
President Obama recently signed the Improving Regulatory Transparency for New Medical Therapies Act into law. The Act…
CME Saves in Overall Healthcare Cost
We have long been vocal proponents of Continuing Medical Education (CME) and the benefits it provides to both the medical…
Washington, D.C. Changes Pharmaceutical Detailer License Requirements
Pharmaceutical and life sciences companies have long used detailing as a way to effectively communicate the benefits and…
Problems Abound with Ohio Drug Price Ballot Petition
As you may recall, we have previously written about ballot initiatives in California and Ohio that are attempting to…
CMS Updates 2014 Open Payments Data
Breaking months of silence on Open Payments data, Centers for Medicare and Medicaid Services (CMS) updated some of the…
Webinar: Managing the Risk of Open Payments – Validate Spend Report Before…
With the next filing period for spend data under the Sunshine Act coming up quickly, Ned Mumtaz and Brian Dahl are…
FDA Fixed Combination and Co-packaging Proposed Rule
Earlier this year the FDA announced its intention to issue a rule on fixed-dose combinations and co-packaged products. On…
The College of Family Physicians of Canada and Commercial Support for CME
Once again, the fact that the pharmaceutical industry helps financially support continuing medical education programs is…